News
Why Cidara Therapeutics Was Such a Healthy Stock Today
Cidara Therapeutics (NASDAQ: CDTX) had some encouraging news to deliver at the end of the trading week, and investors traded the biotech's stock up as a result. It closed Friday nearly 7% higher in
Is Lithium Americas Stock Still a Buy?
The Trump administration wants to own a piece of Lithium Americas (NYSE: LAC), and Wall Street can't decide if that's brilliant or terrifying. The stock spiked this week on reports that the U.S
Why MP Materials Rallied Today
Shares of rare earths miner MP Materials (NYSE: MP) rallied 8% on Thursday.
MP Materials didn't announce any company-specific news, but the stock has rallied since July, when the U.S. government
Why Energy Fuels Stock Just Popped
Lithium Americas (NYSE: LAC) stock doubled Wednesday after Reuters reported the U.S. government may take a 10% stake in the start-up miner of lithium for electric car batteries.
Soon after
Why Standard Lithium Stock Soared Today
Lithium Americas (NYSE: LAC) stock exploded Wednesday morning after Reuters reported that the start-up miner of lithium for electric car batteries may be in line for a big investment from the U.S
Why Lithium Americas Stock Almost Doubled Today
Lithium Americas (NYSE: LAC) stock soared 90.9% through 10 a.m. ET this morning after Reuters reported the start-up miner of lithium for electric car batteries may be in line for a big investment
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%
Prediction: This Artificial Intelligence (AI) Player Could Be the Next Palantir in the 2030s
Palantir (NASDAQ: PLTR) has already shown what it takes to be a successful enterprise artificial intelligence (AI) player: Become the core platform for customers to build their AI applications on
Why Shares of Endava Are Plunging This Week
While Endava (NYSE: DAVA) stock ripped 14.7% higher in August, shares of the tech consultant are off to an auspicious start for September. The company's disappointing fourth-quarter 2025 financial
Why Endava Shares Are Down Today
Endava (NYSE: DAVA) beat quarterly earnings expectations, but the underlying numbers from the British tech consultancy provided little reason for investors to get excited.
Shares of Endava traded
Endava: Trends Moving in Wrong Direction
Here's our initial take on Endava's (NYSE: DAVA) financial report.
We are now 18 months removed from British IT consulting firm Endava seeing its shares lose half their value following a
Finally, a Little Good News for Stellantis Investors
To observers of the automotive industry, it might appear that Stellantis (NYSE: STLA) has been spinning its wheels and driving aimlessly. But its newly appointed CEO, Antonio Filosa, won over at
ImmuCell Q2 Profit Jumps as Margins Rise
ImmuCell(NASDAQ:ICCC) reported results for the three-month period ended June 30, 2025, on August 14, 2025, highlighting a sharp rebound in profitability with adjusted EBITDA of $1.43 million
ImmuCell Posts 18% Gain in Q2
ImmuCell (NASDAQ:ICCC), a specialist in animal health products for the dairy and beef industries, issued its earnings results for the second quarter of fiscal 2025 on August 14, 2025. The company
Cineverse Revenue Jumps 22 Percent in Q1
Cineverse (NASDAQ:CNVS), the streaming technology and media company, reported results on August 14, 2025. The big news: revenue rose to $11.1 million, a 22% increase year over year, fueled by gains
Boxlight Sales Drop 20 Percent
Boxlight (NASDAQ:BOXL), an education technology company specializing in interactive classroom solutions and digital displays, reported its financial results for the second quarter of fiscal 2025 on
Vaxart Revenue Jumps 520% in Fiscal Q2
Vaxart (OTC:VXRT), a biotechnology company focused on developing oral tablet vaccines for infectious diseases, reported its second quarter results on August 13, 2025. The standout headline was a
ParkerVision Posts Wider Loss in Q2
ParkerVision (OTC:PRKR), a developer and licensor of radio frequency (RF) technology patents, released its second quarter 2025 earnings results on August 12, 2025. The filing revealed no licensing
Intellicheck Reports Results
Intellicheck (NASDAQ:IDN), a technology firm specializing in digital identity validation, released financial results for the second quarter on August 12, 2025. The headline news: It achieved record
Neonode Posts 25% Revenue Drop in Q2
Neonode (NASDAQ:NEON), a licensing-focused developer of touch, gesture, and sensing technologies, released its earnings results for the second quarter of fiscal 2025 on August 13, 2025. Top-line
Lithium Argentina Cuts Costs in Q2
Lithium Argentina(NYSE:LAR) reported its second quarter 2025 earnings on August 11, 2025, delivering 8,500 tons of lithium carbonate at $7,400 per ton (down 8% quarter-over-quarter) and reducing
Inuvo (INUV) Q2 Revenue Jumps 25%
Inuvo (NYSEMKT:INUV), an advertising technology company specializing in artificial intelligence (AI)-driven digital audience targeting, released its second quarter 2025 earnings on August 7, 2025
Cidara (CDTX) Q2 Cash Surges 163%
Cidara Therapeutics (NASDAQ:CDTX), a biotechnology company focused on the development of innovative therapies for infectious diseases and oncology, released its second-quarter 2025 earnings on
Piedmont Lithium (PLL) Q2 Loss Beats 31%
Piedmont Lithium (NASDAQ:PLL), a North American lithium developer and producer, released its financial results for Q2 2025 on August 7, 2025. The key highlight was a narrower adjusted
Aemetis (AMTX) Q2 Revenue Falls 33%
Aemetis (NASDAQ:AMTX), a renewable fuels producer with operations in California and India, reported its latest quarterly results on August 7, 2025. The release highlighted a sizable revenue miss